Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07439549Phase 4Recruiting

Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial

Role: collaborator

NCT02661581Not ApplicableCompleted

Peer-led, Empowerment-based, Approach to Self-management Efforts in Diabetes

Role: collaborator

NCT01764568Not ApplicableTerminated

Contrasting Group Therapy Methods for Psychosis

Role: collaborator

NCT03712033Completed

TEC4Home Stroke - Feasibility of Home Telemonitoring Technology in Managing Hypertension Among Stroke/TIA Patients

Role: collaborator

NCT00677196Phase 3Completed

The StoneBreakerTM Trial

Role: collaborator

All 5 trials loaded